Actinium Joins Russell 3000®, Russell 2000®, Russell Global, and Russell Micro-Cap® Indexes Jul 1, 2014
Preeminent Oncology Clinicians from Leading Cancer Centers Join Actinum’s Newly Established Iomab-B Scientific Advisory Board Jun 26, 2014
Actinium’s Actimab-A and Alpha-Particle Immunotherapy Platform Further Validated at Society for Nuclear Medicine Annual Meeting Jun 24, 2014
Actinium Set to Join Russell 3000®, Russell 2000®, Russell Global, and Russell Micro-Cap® Indexes Jun 17, 2014
Panelists at NewYorkBIO-CONference Highlight Prior Clinical Data Showing Iomab™-B Improves Survival and is Well-Tolerated Jun 11, 2014
